TNSN92115A1 - BENZIMIDAZOLES SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE - Google Patents

BENZIMIDAZOLES SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE

Info

Publication number
TNSN92115A1
TNSN92115A1 TNTNSN92115A TNSN92115A TNSN92115A1 TN SN92115 A1 TNSN92115 A1 TN SN92115A1 TN TNSN92115 A TNTNSN92115 A TN TNSN92115A TN SN92115 A TNSN92115 A TN SN92115A TN SN92115 A1 TNSN92115 A1 TN SN92115A1
Authority
TN
Tunisia
Prior art keywords
preparation
benzimidazoles
substitutes
compounds
intermediates
Prior art date
Application number
TNTNSN92115A
Other languages
French (fr)
Inventor
Bjorn Christer Holstein Kark
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN92115A1 publication Critical patent/TNSN92115A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Abstract

LA PRESENTE INVENTION PORTE SUR DE NOUVEAUX COMPOSES AYANT UNE ACTIVITE THERAPEUTIQUE, INTERMEDIAIRES POUR LEUR PREPARATION, PROCEDES DE LEUR PREPARATION, FORMULATIONS PHARMACEUTIQUES CONTENANT LESDITS COMPOSES ET UTILISATION MEDICALE DESDITS COMPOSES ET DE COMPOSES CONNUS ANALOGUESTHE PRESENT INVENTION RELATES TO NEW COMPOUNDS HAVING THERAPEUTIC ACTIVITY, INTERMEDIATES FOR THEIR PREPARATION, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING SAID COMPOUNDS AND MEDICAL USE OF SAID COMPOUNDS AND SIMILAR COMPOUNDS

TNTNSN92115A 1991-12-19 1992-12-18 BENZIMIDAZOLES SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE TNSN92115A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103776A SE9103776D0 (en) 1991-12-19 1991-12-19 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
TNSN92115A1 true TNSN92115A1 (en) 1993-06-08

Family

ID=20384667

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92115A TNSN92115A1 (en) 1991-12-19 1992-12-18 BENZIMIDAZOLES SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE

Country Status (25)

Country Link
EP (1) EP0628049A1 (en)
JP (1) JPH07502503A (en)
KR (1) KR940703840A (en)
CN (1) CN1031827C (en)
AP (1) AP397A (en)
AU (1) AU665043B2 (en)
CA (1) CA2124689A1 (en)
CZ (1) CZ146794A3 (en)
FI (1) FI942912A (en)
HR (1) HRP921400A2 (en)
HU (1) HUT68270A (en)
IL (1) IL104025A0 (en)
IS (2) IS4079A (en)
MA (1) MA22746A1 (en)
MX (1) MX9207269A (en)
NO (1) NO942230L (en)
NZ (1) NZ246220A (en)
SE (1) SE9103776D0 (en)
SI (1) SI9200402A (en)
SK (1) SK73594A3 (en)
TN (1) TNSN92115A1 (en)
TW (1) TW224100B (en)
WO (1) WO1993012124A1 (en)
YU (1) YU101692A (en)
ZA (1) ZA928836B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19645974C1 (en) * 1996-11-07 1998-08-13 Andreas Johannes Kesel (Z) -5 - [[3-Hydroxy-2-methyl-5 - [(phosphonooxy) methyl] -4-pyridinyl] methylene] -2-thioxo-4-thiazolidinone, process for its preparation and use
WO1999033846A2 (en) * 1997-12-31 1999-07-08 The University Of Kansas Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
ATE467637T1 (en) 2005-07-28 2010-05-15 Intervet Int Bv NEW BENZIMIDAZOLE(THIO)CARBAMATES WITH ANTIPARASITIC EFFECT AND THEIR SYNTHESIS
TWI385169B (en) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd Heterocyclic substituted pyridine derivatives and antifungal agent containing same
PL2037914T3 (en) 2006-06-14 2014-04-30 Intervet Int Bv A suspension comprising benzimidazole carbamate and a polysorbate
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
MX365051B (en) 2014-11-26 2019-05-09 Univ Mexico Nac Autonoma Novel hydrosoluble compounds derived from benzimidazole used in treating fasciolosis.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8801907D0 (en) * 1988-05-20 1988-05-20 Haessle Ab NOVEL PHARMACOLOGICAL COMPOUNDS
SE9002206D0 (en) * 1990-06-20 1990-06-20 Haessle Ab NEW COMPOUNDS
WO1991019712A1 (en) * 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use

Also Published As

Publication number Publication date
MA22746A1 (en) 1993-07-01
AU3175293A (en) 1993-07-19
TW224100B (en) 1994-05-21
CN1073446A (en) 1993-06-23
FI942912A0 (en) 1994-06-17
NO942230D0 (en) 1994-06-14
AP397A (en) 1995-08-14
ZA928836B (en) 1993-07-05
HUT68270A (en) 1995-06-28
YU101692A (en) 1995-10-03
HU9401840D0 (en) 1994-09-28
AU665043B2 (en) 1995-12-14
MX9207269A (en) 1993-06-01
IS4079A (en) 1993-06-20
CA2124689A1 (en) 1993-06-24
KR940703840A (en) 1994-12-12
SE9103776D0 (en) 1991-12-19
NZ246220A (en) 1996-02-27
HRP921400A2 (en) 1994-08-31
SI9200402A (en) 1993-06-30
EP0628049A1 (en) 1994-12-14
CN1031827C (en) 1996-05-22
SK73594A3 (en) 1995-02-08
FI942912A (en) 1994-06-17
AP9200463A0 (en) 1993-01-31
JPH07502503A (en) 1995-03-16
NO942230L (en) 1994-06-14
CZ146794A3 (en) 1996-02-14
IL104025A0 (en) 1993-05-13
IS3960A (en) 1993-06-20
WO1993012124A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
Seltzer et al. Flare-ups in endodontics: I. Etiological factors
RU94038043A (en) Use of the substituted adenine derivatives for multiple sclerosis treatment
FR2442054A1 (en) PURIFIED PROTEINS, IN PARTICULAR INTERFERON, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY23665A1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOUND
DE3582439D1 (en) MEDICINE FOR TREATING HEART DISEASES.
HUP9902105A2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
RU95109905A (en) Liquid, semisolid, solid, gel-like or paste-like compositions and a method of mouth cavity disease treatment
FR2512670B1 (en) CAPSULES CONTAINING THE ACTIVE INGREDIENT OF AN ALLERGEN AND PROCESS FOR THEIR PREPARATION
LV12766A (en) Composition of l-dopa esters
MX9605940A (en) Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization.
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
UA40589C2 (en) method for treating a human suffering from viral infection, pharmaceutical composition, combination of compounds for the preparation of medications and pharmaceutical combination
DE69132688D1 (en) METHOD FOR TREATING AND PREVENTING TYPE-1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
DE69510190D1 (en) USE OF FATTY ACID ESTERS AS BIO ADHESIVES
YU215090A (en) PULLED FORMULATION FOR CONTROLLED RELEASE
RU94026283A (en) Pharmaceutical compound
ES8800946A1 (en) Derivatives of Guanine, process for their preparation and a pharmaceutical preparation.
ATE268605T1 (en) PHARMACEUTICAL ACCEPTABLE DNASE COMPOSITION
CA2392165A1 (en) Vitamin d analogues
TNSN92115A1 (en) BENZIMIDAZOLES SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE
DE3879873D1 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
RU95101385A (en) Products containing g-csf and tnf-binding protein
JPS62265222A (en) Cell membrane lipid structure and function modification and pharmaceutical composition therefor
FR2713640B1 (en) New polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses.
KR950031063A (en) Using pravastatin to slow the progression of coronary atherosclerosis